Skip to content

Clinical trials

Completed Observational Thromboembolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Observational Status: Completed Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20043
20052
20062
20073
20083
20092
20103
20112
20125
20134
20143
20154
20164
20173
20184
20192
202012
20212
20225
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed76

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Boehringer Ingelheim3
Brigham and Women's Hospital3
GlaxoSmithKline3
Karolinska Institutet3
Abbott Medical Devices2
Celgene2
Inari Medical2
AHEPA University Hospital1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism76
Thrombosis12
Venous Thromboembolism12
Venous Thrombosis12
Pulmonary Embolism11
Atrial Fibrillation10
COVID-1910
Hemorrhage8
Cardiovascular Diseases7
Stroke6

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.